Margolis D, Watkins M, Zhu Y. Two phase 1 studies of safety, tolerability, and pharmacokinetics of an EFdA prodrug (BRII-732) in healthy adult participants. Antimicrob Agents Chemother 2025 Apr 22:e0020025. doi: 10.1128/aac.00200.
PMID: 40261081